TACE is most effective in treating primary liver cancers, such as hepatocellular carcinoma. It is also used for treating metastatic liver cancers, which are cancers that have spread to the liver from other parts of the body. In some cases, TACE may also be employed for treating other types of tumors, such as neuroendocrine tumors and certain sarcomas.
